TipRanks
Protalix Biotherapeutics (PLX)
:PLX
US Market
PLX
Protalix
RESEARCH TOOLSreports
Want to see PLX full AI Analyst Report?

Protalix (PLX) Ownership - Who Owns Protalix?

961 Followers

Protalix (PLX) Ownership Overview

3.87%2.82%0.09%5.46%87.76%
3.87% Insiders
2.82% Mutual Funds
0.09% Other Institutional Investors
5.46% ETFs
87.76% Public Companies and
Individual Investors
The ownership structure of Protalix (PLX) stock is a mix of institutional, retail, and individual investors. Approximately 8.37% of the company’s stock is owned by Institutional Investors, 3.87% is owned by Insiders, and 87.76% is owned by Public Companies and Individual Investors.
The ownership structure of Protalix (PLX) stock is a mix of institutional, retail, and individual investors. Approximately 2.91% of the company’s stock is owned by Institutional Investors, 3.87% is owned by Insiders, and 5.46% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Dec 23, 2025
Dror Bashan
xxxxxxxxxxxxx
$101360
Nov 19, 2025
Amos Bar Shalev
xxxxxxxxxxxxx
$314
Show More Insider Trading Activity >

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
2,885,363Institution3.58%7,415,383
2,532,934Insider3.14%6,509,640
775,621Institution0.96%1,993,346
557,337Institution0.69%1,432,356
427,642Institution0.53%1,099,040
378,918Institution0.47%973,819
341,207Institution0.42%876,902
310,500Insider0.39%797,985
232,929Insider0.29%598,628
180,000Institution0.22%462,600

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
775,621Institution0.96%1,993,346
427,642Institution0.53%1,099,040
341,207Institution0.42%876,902
180,000Institution0.22%462,600
159,311Institution0.20%409,429
87,280Institution0.11%224,310
78,711Institution0.10%202,287
63,135Institution0.08%162,257
33,278Institution0.04%85,524
27,900Institution0.03%71,703

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
iShares
1,902,343Institution2.36%4,889,022
iShares
742,233Institution0.92%1,907,539
Vanguard
464,504Institution0.58%1,282,031
DFA
251,244Institution0.31%690,921
iShares
244,797Institution0.30%629,128
Bridgeway
98,344Institution0.12%259,628
DFA
87,623Institution0.11%239,211
Dimensional
87,615Institution0.11%207,648
Vanguard
87,170Institution0.11%240,589
SPDR
86,201Institution0.11%227,571

FAQ

Who Owns Protalix Biotherapeutics (PLX)?
According to the latest TipRanks data, approximately 0.09% of the company's stock is held by institutional investors, 3.87% is held by insiders, and 87.76% is held by retail investors.
    What percentage of Protalix Biotherapeutics (PLX) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 0.09% of Protalix Biotherapeutics (PLX) stock is held by institutional investors.
      What percentage of Protalix Biotherapeutics (PLX) stock is held by retail investors?
      According to the latest TipRanks data, approximately 87.76% of Protalix Biotherapeutics (PLX) stock is held by retail investors.
        Who owns the most shares of Protalix Biotherapeutics (PLX)?
        iShares owns the most shares of Protalix Biotherapeutics (PLX).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.